You are here: Home / Publications / Urokinase-type plasminogen activator receptor: a beacon of malignancy?

Urokinase-type plasminogen activator receptor: a beacon of malignancy?

18794069

Clin. Cancer Res.. 2008 Sep 14 (18).

Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Identification of serum biomakers that can rellably make the distinction would aid in the proper referral for patient care and may provide leads in the development of early detection strategies.

This icon signifies that something is happening and we kindly ask you to please wait